Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP

Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to onshore the manufacture of Epinephrine Injection, USP, an essential medicine long at risk of chronic shortage in the ...
Contract Pharma

Fresenius Kabi, Phlow Partner to Onshore the Manufacture of Epinephrine Injection in the U.S.

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® (epinephrine nasal spray) at 2026 American Academy of Allergy, Asthma and Immunology ...

Five poster presentations highlight clinical advancement of neffy, real-world usability and advantages of needle-free epinephrine delivery -Longer shelf life of nasal epinephrine compared with ...
Business Wire

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, ...
CBS News

First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative

A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...